U.S. Auto Stock News

If you are wondering whether Main Street Capital at around US$51.74 is attractively priced or asking too much for its prospects, you are asking the right question for this stock. The share price is down 0.5% over the past week, 2.2% over the past month, and 16.2% year to date, even though the 3 year and 5 year returns sit at 67.3% and 82.6% respectively. Recent attention on Main Street Capital has centered on how its business development model fits into a higher rate backdrop and what that...

In recent days, The Cheesecake Factory’s first-quarter 2026 results showed a 1.6% increase in same-store sales, and JPMorgan shifted its rating on the stock from Underweight to Neutral. This combination of improving same-store performance and a more constructive analyst stance has sharpened attention on the company’s profit margin outlook and overall business momentum. With profit margins now under a brighter spotlight following the strong quarter, we’ll explore how this development...

ADESA, Carvana's wholesale auction platform, has launched ADESA Timed, a new self-service digital auction product. The product expands digital selling tools to a broader group of wholesale auto sellers. This development marks an expansion of Carvana's B2B digital footprint beyond its core consumer facing retail platform. Carvana (NYSE:CVNA) is adding this new capability while its stock trades at $67.82, with a very large 3 year return and a 1 year return of 6.3%. The share price is up 2.5%...

This article examines whether Uranium Energy at US$10.63 still offers value or if the easy gains are behind it, and explores what the current price may be implying about the stock. The share price has been volatile recently, with the stock down 24.8% over the past week and 31.4% over the past month. It remains up 70.6% over the past year and about 3.3x over the past three years. Recent moves in uranium related stocks have kept attention on the sector as investors weigh long term demand for...

Vaxcyte recently dosed the first participant in its Phase 1, first-in-human trial of VAX-A1, a prophylactic Group A Streptococcus vaccine candidate being tested in about 80 healthy adults in Australia to assess safety, tolerability and initial immune responses. This marks an early but important step in expanding Vaxcyte’s pipeline beyond pneumococcal vaccines into a second high-burden infectious disease area with no approved vaccine. We’ll now examine how initiating first-in-human testing...

If you are wondering whether Dollar General stock offers good value at around US$114.34, the starting point is understanding how its current price lines up against a range of valuation checks. The stock has recently moved sharply, with a gain of 10.5% over the past week and 11.0% over the past month, even though the year to date return is a decline of 16.4% and the 5 year return is a decline of 41.9%. Those mixed returns give important context for today’s price, especially as investors weigh...

GDS Holdings stock snapshot after recent performance shifts GDS Holdings (NasdaqGM:GDS) has drawn fresh attention after a mixed stretch, with the stock up 0.8% on the day but down about 21% over the past month and past 3 months. At a last close of US$33.76 and a market value near US$6.7b, the company continues to focus on developing and operating data centers in China while offering colocation, managed hosting, managed cloud and consulting services. See our latest analysis for GDS...

Aeva Technologies (AEVA) is back in focus after Fargo, North Dakota selected its CityOS traffic intelligence platform for deployment across multiple intersections, putting the company’s 4D LiDAR and AI system into everyday urban use. See our latest analysis for Aeva Technologies. The Fargo contract and recent CityOS showcases have arrived alongside a sharp swing in sentiment, with a 30 day share price return of 23.15% and a year to date share price return of 84.39% contrasting with a flat 1...

If you are wondering whether Dave's current share price reflects its fundamentals, this breakdown will help you assess what you are really paying for. Dave's stock recently closed at US$285.43, with returns of 9.1% over the past week, 17.8% over the past month and 30.0% year to date. This naturally raises questions about how much value is already in the price. Over the last year the stock has delivered a 19.8% return, while the 3 year return figure is very large. This puts more attention on...

With the Federal Reserve now signaling that interest rate hikes are on the way, short duration fixed income and money market funds are back in the spotlight as investors weigh higher borrowing costs, slower growth risk, and pressure on stock valuations. This article uses a targeted screener built around that Fed shift to highlight where the news may matter most. You will see three stocks held by investment grade short-term funds that look relatively well positioned for this rate story, why...

Crocs (CROX) is drawing fresh attention after teaming up with SuperOrdinary on Déjà Shoe, a TikTok microdrama that lets viewers shop tagged products directly inside episodes, blending entertainment with social commerce. See our latest analysis for Crocs. The Déjà Shoe campaign and recent broker upgrades arrive as momentum in Crocs' share price has picked up, with a 30 day share price return of 26.7% and a 90 day share price return of 61.5%. The 1 year total shareholder return stands at 21.4%,...

Some STERIS plc ( NYSE:STE ) shareholders may be a little concerned to see that the President, Daniel Carestio...

If you are wondering whether Shake Shack's current share price really reflects what the business is worth, the starting point is to look closely at how the market is valuing it today. The stock closed at US$58.33, with a gain of 9.3% over the past week, but it is still down 11.7% over the past month, 30.1% year to date and 54.5% over the past year, which naturally raises questions about both risk and potential recovery. Recent coverage has focused on how a prolonged share price decline...

Ameren’s new capital plan and why it matters Ameren (AEE) is drawing attention after outlining a US$31.8b capital plan for 2026 to 2030. The company is targeting infrastructure upgrades, grid modernization and renewable energy projects linked to rising data center electricity demand. See our latest analysis for Ameren. Ameren’s recent US$31.8b capital plan arrives as the share price sits at US$108.25, with the stock up 7.33% on a year to date share price basis and a 1 year total shareholder...

Investors may be wondering if Xcel Energy at around US$78.27 is offering fair value right now, or if the price is outpacing what the fundamentals might support. The stock is up 0.6% over the last week, slightly down 2.0% over the past month, up 4.8% year to date, and shows returns of 16.9% over 1 year, 33.8% over 3 years, and 33.3% over 5 years. These figures can influence how investors think about both opportunity and risk. Recent headlines around Xcel Energy have focused on its role as a...

What recent performance says about Corteva stock Corteva (CTVA) has drawn attention after a mixed stretch for the stock, with a small gain over the past day, declines over the past week, month, and past 3 months, yet a positive move year to date. This performance backdrop is prompting investors to look more closely at how the company’s current valuation lines up with its agricultural seed and crop protection business, as well as recent revenue and net income trends. See our latest analysis...

Recent developments in the Cloud AI landscape include Akamai Technologies earning a Solutions Partner with certified software designation for its API Security within the Microsoft AI Cloud Partner Program. This certification underscores the interoperability of Akamai's software with the Microsoft Cloud, offering cross-platform visibility and security for users operating in cloud environments like Microsoft Azure. This advancement emphasizes the growing demand for robust API protection as AI...

Some ServiceTitan, Inc. ( NASDAQ:TTAN ) shareholders may be a little concerned to see that the Chief Accounting...

Some Burlington Stores, Inc. ( NYSE:BURL ) shareholders may be a little concerned to see that the EVP & Chief Human...

South Korea’s Personal Information Protection Commission has fined Coupang (NYSE:CPNG) more than US$400m after a major data breach. The breach exposed personal information of over 33 million customers and regulators found the company did not detect it within the required timeframe. Authorities also ruled that Coupang illegally collected data from millions of customers, adding to the scale of the sanctions. Coupang runs one of South Korea’s largest e commerce platforms, with delivery,...

Agnico Eagle Mines (NYSE:AEM) has received approval for a renewed normal course issuer bid. The program allows the company to repurchase and cancel up to 25 million shares. The buyback is framed as part of Agnico Eagle’s broader capital allocation plans. Agnico Eagle Mines is a major gold producer, so this new buyback comes at a time when investors are watching precious metals companies for capital return decisions as much as production updates. For you as a shareholder or potential...

Investors may wish to note that the Executive VP & Chief Lending Officer of Princeton Bancorp, Inc. , Stephanie Adkins...

LPL Financial recently participated in the Morgan Stanley US Financials Conference 2026 and announced several advisor additions, including Darren Colananni and Les Smith, who launched or joined practices on its broker-dealer and RIA platform with hundreds of millions of client assets. Genesis Wealth, an LPL-affiliated platform, reported that advisors now serve more than US$3.00 billion in client assets through organic growth, underscoring LPL’s appeal to experienced advisors seeking...

Harmony Biosciences Holdings recently announced that six abstracts on narcolepsy and idiopathic hypersomnia, featuring clinical and patient-experience data on pitolisant, were accepted for poster presentation at the SLEEP 2026 APSS meeting in Baltimore. This concentration of late-stage data highlights how Harmony is working to deepen the clinical profile of its core sleep-wake franchise at a time when investors are closely watching its broader neurology pipeline. We’ll now examine how the...